Senior insider sale
CEO & President at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$19.74M
40K shares
What this filing means
KEWALRAMANI RESHMA plans to sell 40K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $19.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0001959173-26-001605
DirectorOfficer· CEO & President
Since Feb 2026
40K
Shares to sell
$19.74M
Approx. market value
40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Restricted Stock Vesting
Compensation
2/26/2025
15.04KRestricted Stock Vesting
Compensation
2/24/2025
8.28KRestricted Stock Vesting
Compensation
2/17/2025
7KRestricted Stock Vesting
Compensation
2/10/2025
9.68KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2025 | Restricted Stock Vesting Compensation | 15.04K | — |
2/24/2025 | Restricted Stock Vesting Compensation | 8.28K | — |
2/17/2025 | Restricted Stock Vesting Compensation | 7K | — |
2/10/2025 | Restricted Stock Vesting Compensation | 9.68K | — |
| Total | 40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
40K
Market value
$19.74M
2/27/2026
Total
Units
40K
Value
$19.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/27/2026 | 40K | $19.74M | NASDAQ | Planned |
| Total | 40K | $19.74M | ||